Cas no 259110-61-7 (trans-3,5-difluoropiperidine;hydrochloride)

Technical Introduction: trans-3,5-Difluoropiperidine Hydrochloride trans-3,5-Difluoropiperidine hydrochloride is a fluorinated piperidine derivative widely used as a key intermediate in pharmaceutical synthesis and medicinal chemistry. The trans-configuration ensures structural specificity, while the difluorination enhances metabolic stability and bioavailability. Its hydrochloride salt form improves solubility and handling, facilitating precise dosing in research applications. This compound is particularly valuable in the development of bioactive molecules, including CNS-targeting drugs and enzyme inhibitors. High purity and consistent quality make it suitable for rigorous synthetic workflows. Its unique stereochemistry and fluorine substitution pattern contribute to its utility in optimizing drug candidates for improved pharmacokinetic properties.
trans-3,5-difluoropiperidine;hydrochloride structure
259110-61-7 structure
Product Name:trans-3,5-difluoropiperidine;hydrochloride
CAS No:259110-61-7
MF:C5H10ClF2N
MW:157.589407444
MDL:MFCD30803927
CID:4761154
PubChem ID:145708189
Update Time:2026-02-26

trans-3,5-difluoropiperidine;hydrochloride Chemical and Physical Properties

Names and Identifiers

    • rel-(3R,5R)-3,5-Difluoropiperidine hydrochloride
    • trans-3,5-difluoropiperidine;hydrochloride
    • F85935
    • rel-(3R,5R)-3,5-Difluoropiperidinehydrochloride
    • trans-3,5-difluoropiperidine hydrochloride
    • 2940873-30-1
    • (3R,5R)-3,5-DIFLUOROPIPERIDINE HYDROCHLORIDE
    • CS-0187950
    • (3R,5R)-3,5-difluoropiperidine;hydrochloride
    • BS-16328
    • (3S,5S)-3,5-DIFLUOROPIPERIDINE HYDROCHLORIDE
    • AKOS037649030
    • P21019
    • 259110-61-7
    • MDL: MFCD30803927
    • Inchi: 1S/C5H9F2N.ClH/c6-4-1-5(7)3-8-2-4;/h4-5,8H,1-3H2;1H/t4-,5-;/m1./s1
    • InChI Key: AHGKXYJWIFNPNB-TYSVMGFPSA-N
    • SMILES: Cl.F[C@H]1CNC[C@@H](C1)F

Computed Properties

  • Exact Mass: 157.0469833g/mol
  • Monoisotopic Mass: 157.0469833g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 9
  • Rotatable Bond Count: 0
  • Complexity: 68.8
  • Covalently-Bonded Unit Count: 2
  • Defined Atom Stereocenter Count: 2
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 12

trans-3,5-difluoropiperidine;hydrochloride Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-UJ841-50mg
trans-3,5-difluoropiperidine;hydrochloride
259110-61-7 95%
50mg
2293CNY 2021-05-07
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-UJ841-100mg
trans-3,5-difluoropiperidine;hydrochloride
259110-61-7 95%
100mg
1387.0CNY 2021-07-15
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.
R57340-250mg
rel-(3R,5R)-3,5-Difluoropiperidine hydrochloride
259110-61-7 95%
250mg
¥3699.0 2024-07-19
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.
R57340-100mg
rel-(3R,5R)-3,5-Difluoropiperidine hydrochloride
259110-61-7 95%
100mg
¥270.0 2024-07-19
Chemenu
CM515789-50mg
rel-(3R,5R)-3,5-Difluoropiperidine hydrochloride
259110-61-7 95%
50mg
$275 2022-09-01
Chemenu
CM515789-100mg
rel-(3R,5R)-3,5-Difluoropiperidine hydrochloride
259110-61-7 95%
100mg
$347 2022-09-01
Chemenu
CM515789-250mg
rel-(3R,5R)-3,5-Difluoropiperidine hydrochloride
259110-61-7 95%
250mg
$556 2022-09-01
eNovation Chemicals LLC
D657326-100mg
trans-3,5-difluoropiperidine;hydrochloride
259110-61-7 97%
100mg
$365 2024-07-21
eNovation Chemicals LLC
D657326-250MG
trans-3,5-difluoropiperidine;hydrochloride
259110-61-7 97%
250mg
$605 2024-07-21
eNovation Chemicals LLC
D657326-500MG
trans-3,5-difluoropiperidine;hydrochloride
259110-61-7 97%
500mg
$850 2024-07-21

Additional information on trans-3,5-difluoropiperidine;hydrochloride

Comprehensive Guide to trans-3,5-difluoropiperidine hydrochloride (CAS No. 259110-61-7): Properties, Applications, and Market Insights

trans-3,5-difluoropiperidine hydrochloride (CAS No. 259110-61-7) is a fluorinated piperidine derivative that has garnered significant attention in pharmaceutical and agrochemical research. This compound belongs to the class of fluorinated heterocycles, which are known for their unique physicochemical properties and broad applications in drug discovery. The trans-configuration of the fluorine atoms at the 3 and 5 positions of the piperidine ring enhances its structural stability and bioavailability, making it a valuable intermediate in synthetic chemistry.

The growing demand for fluorinated building blocks in medicinal chemistry has positioned trans-3,5-difluoropiperidine hydrochloride as a key player in the development of novel therapeutics. Researchers are particularly interested in its potential to improve the metabolic stability and binding affinity of drug candidates. Recent studies highlight its utility in the synthesis of kinase inhibitors and G protein-coupled receptor (GPCR) modulators, addressing pressing medical needs such as oncology and central nervous system disorders.

From a chemical perspective, trans-3,5-difluoropiperidine hydrochloride exhibits remarkable solubility in polar solvents like water and methanol, which facilitates its use in various reaction conditions. Its hydrochloride salt form ensures better handling and storage stability, a critical factor for industrial-scale applications. The compound's high purity and consistent quality are essential for reproducible results in both academic and commercial research settings.

In the context of green chemistry, the synthesis of trans-3,5-difluoropiperidine hydrochloride has evolved to minimize environmental impact. Modern catalytic methods, including flow chemistry and microwave-assisted synthesis, have improved yields while reducing waste generation. These advancements align with the global push toward sustainable chemical manufacturing, a topic of high relevance in today's research landscape.

The market for fluorinated piperidines is expanding rapidly, driven by their increasing incorporation into FDA-approved drugs. Analysts project a compound annual growth rate (CAGR) of 6-8% for this segment over the next decade. trans-3,5-difluoropiperidine hydrochloride is particularly sought after by contract research organizations (CROs) and pharmaceutical companies focusing on central nervous system drugs and anti-inflammatory agents.

Quality control is paramount when working with trans-3,5-difluoropiperidine hydrochloride. Reputable suppliers provide comprehensive analytical data, including HPLC chromatograms, NMR spectra, and mass spectrometry results, to verify the compound's identity and purity. Researchers should always source this material from certified vendors to ensure compliance with Good Laboratory Practice (GLP) standards.

Looking ahead, the versatility of trans-3,5-difluoropiperidine hydrochloride suggests its continued importance in cutting-edge research. Its applications may extend to emerging fields such as proteolysis targeting chimeras (PROTACs) and covalent inhibitors, which represent revolutionary approaches in drug development. As the scientific community addresses challenges like drug resistance and targeted therapy, this compound will likely play a pivotal role in next-generation pharmaceutical innovations.

For researchers considering trans-3,5-difluoropiperidine hydrochloride for their projects, proper handling procedures should be followed despite its non-hazardous classification. Standard laboratory precautions, including the use of personal protective equipment and proper ventilation, are recommended when working with any chemical substance. The compound's Material Safety Data Sheet (MSDS) provides detailed guidance on storage conditions and handling protocols.

In conclusion, trans-3,5-difluoropiperidine hydrochloride (CAS No. 259110-61-7) stands as a testament to the importance of fluorinated heterocycles in modern chemistry. Its unique structural features, combined with growing pharmaceutical applications, make it a compound of significant interest across multiple research disciplines. As synthetic methodologies advance and new therapeutic targets emerge, this molecule will undoubtedly continue to contribute to scientific progress and innovation.

Recommended suppliers
Zhangzhou Sinobioway Peptide Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zhangzhou Sinobioway Peptide Co.,Ltd.
Zhejiang Brunova Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hubei Cuiyuan Biotechnology Co.,Ltd
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Jinan Hanyu Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinan Hanyu Chemical Co.,Ltd.